CA Patent

CA2678367C — Sustained release compositions using wax-like materials

Assigned to Farnam Companies Inc · Expires 2014-07-08 · 12y expired

What this patent protects

Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent are provided. Oral dosage forms comprising said pellets and methods for preparing and using such pellets and dosage forms are also provided.

USPTO Abstract

Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent are provided. Oral dosage forms comprising said pellets and methods for preparing and using such pellets and dosage forms are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2678367C
Jurisdiction
CA
Classification
—
Expires
2014-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Farnam Companies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.